TD Cowen Cuts Procter & Gamble (NYSE:PG) Price Target to $150.00

Procter & Gamble (NYSE:PG) had its price target decreased by TD Cowen from $168.00 to $150.00 in a research note published on Thursday morning,Benzinga reports. TD Cowen currently has a buy rating on the stock.

A number of other research analysts also recently weighed in on PG. UBS Group dropped their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Jefferies Financial Group upgraded Procter & Gamble from a “hold” rating to a “buy” rating and increased their target price for the stock from $156.00 to $179.00 in a report on Tuesday, December 16th. Cowen restated a “buy” rating on shares of Procter & Gamble in a research note on Thursday. Berenberg Bank upped their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. Finally, BNP Paribas Exane reduced their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday, September 23rd. Fifteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $169.23.

Procter & Gamble Stock Up 0.2%

Procter & Gamble stock opened at $141.81 on Thursday. The company has a market capitalization of $331.37 billion, a PE ratio of 20.70, a PEG ratio of 4.78 and a beta of 0.39. Procter & Gamble has a 12-month low of $137.62 and a 12-month high of $179.99. The firm’s fifty day moving average is $144.93 and its 200 day moving average is $151.50. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.09. The firm had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The business’s revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, sell-side analysts predict that Procter & Gamble will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Friday, October 24th were given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, October 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 61.61%.

Insiders Place Their Bets

In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 725 shares of the company’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $149.57, for a total value of $108,438.25. Following the completion of the sale, the chief accounting officer directly owned 979 shares of the company’s stock, valued at approximately $146,429.03. This represents a 42.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. First Heartland Consultants Inc. raised its holdings in shares of Procter & Gamble by 4.2% in the 4th quarter. First Heartland Consultants Inc. now owns 6,774 shares of the company’s stock worth $973,000 after purchasing an additional 273 shares during the period. Constitution Capital LLC increased its position in Procter & Gamble by 27.5% in the fourth quarter. Constitution Capital LLC now owns 31,449 shares of the company’s stock worth $4,507,000 after buying an additional 6,780 shares during the last quarter. Keb Asset Management LLC raised its stake in shares of Procter & Gamble by 7.3% in the fourth quarter. Keb Asset Management LLC now owns 1,685 shares of the company’s stock valued at $241,000 after buying an additional 114 shares during the period. Capital Asset Advisory Services LLC lifted its position in shares of Procter & Gamble by 4.1% during the 4th quarter. Capital Asset Advisory Services LLC now owns 32,209 shares of the company’s stock valued at $4,506,000 after buying an additional 1,271 shares during the last quarter. Finally, Somerset Trust Co grew its stake in shares of Procter & Gamble by 2.5% during the 4th quarter. Somerset Trust Co now owns 22,286 shares of the company’s stock worth $3,194,000 after acquiring an additional 534 shares during the period. 65.77% of the stock is owned by institutional investors.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Seeking Alpha argues the market is wrong and P&G is a buy — the piece upgrades the rating, highlighting durable cash flows and long-term compounding potential that could attract value investors. Procter & Gamble: The Market Is Wrong – It’s Time To Buy This Compounder (Rating Upgrade)
• Positive Sentiment: TD Cowen cut its price target (to $150) but maintained a Buy — signals some near-term valuation cooling yet continued analyst conviction that P&G has upside from current levels. Benzinga
• Neutral Sentiment: Zacks notes P&G is a trending stock and summarizes factors investors should watch (demand trends, promotions, dividend profile), useful for short-term traders but not a firm directional catalyst. Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Analysis on Yahoo Finance frames the story as a trade-off: legal scrutiny vs. new CEO emphasis on pricing — legal risk raises uncertainty, but stronger pricing execution would support margins and investor confidence. Should Legal Scrutiny And New CEO Focus On Pricing Shape Procter & Gamble’s (PG) Investment Narrative?
• Negative Sentiment: Regulatory action: P&G agreed to change Crest kids’ toothpaste packaging after concerns raised by the Texas AG — this creates near-term legal/regulatory overhang and potential reputational risk. Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
• Negative Sentiment: Wells Fargo trimmed its price target (to $158 from $170) as 2026 models were reset — the cut, even with an Overweight call, signals lower near-term upside from previous analyst expectations. Wells Fargo Trims Procter & Gamble (PG) Target as 2026 Models Reset
• Negative Sentiment: Market-watch pieces and a Seeking Alpha “still not a buy” write-up highlight valuation concerns (multiples vs. growth) and recent softness in category demand — these narratives feed selling pressure and explain continued volatility. Procter & Gamble: A Wide Moat, Solid Business – And Still Not A Buy
• Negative Sentiment: Short-term technical/market signal: coverage flagged P&G hitting a 52-week low recently, which can amplify downside momentum as momentum traders and funds react. Procter & Gamble Hits 52-Week Low: Buy Opportunity or Warning Sign?

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.